Study: BioNTech vaccine effective against mutation

The corona vaccine developed by BioNTech and Pfizer also protects against a mutation of the virus that has emerged in the UK and South Africa, according to a new study. The variants of the virus first discovered in the UK and South Africa feature a mutation that did not block the vaccine in the study. The study was published on the Internet for researchers and has not yet been reviewed by experts.

The mutation, called N501Y, is a slight change in a site of the spike protein on the surface of the virus. This change is thought to be the reason why the two variants can spread so quickly. Most vaccines being rolled out around the world teach the bodies of those vaccinated to recognize and fight the spike protein.

I like sports and food.
Card reviewed by: @ericof